CIK 0002022416 · <br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K/A Event Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 8 of 15 · 283 filings